Anti-SLC34A2 (Lifastuzumab) -SMCC-DM1
Selected Variant
T9901A-1042-01
Size: 1 mg
Product Specifications
Target
Microtubule Associated, Sodium Channel, Antibody-Drug Conjugates (ADCs)
Related Pathways
Membrane transporter/Ion channel, Cytoskeletal Signaling, Antibody-drug Conjugate/ADC Related
Bioactivity
Anti-SLC34A2 (Lifastuzumab) -SMCC-DM1 is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the SMCC linker and the cytotoxic microtubule inhibitor DM1. The ADC's toxic and linker components are SMCC-DM1. Anti-SLC34A2 (Lifastuzumab) -SMCC-DM1 can be used for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog